Chromatography column qualification in manufacturing methods for producing anti-TNF antibody compositions
AssigneeJanssen Biotech, Inc.
InventorPaul Randolph
Life of this patent
Estimating the term…
Loading patent…
AssigneeJanssen Biotech, Inc.
InventorPaul Randolph
Estimating the term…
A method of operating a chromatography column is described for use in methods of manufacture for producing anti-TNF antibodies, e.g., the anti-TNFα antibody SIMPONI® (golimumab). This method involves collecting column outlet signal and accumulated flow parameters at two or more intervals of at least one mobile phase transition front during operation of the chromatography column comprising column packing. A model gamma cumulative distribution curve is calculated based on the collected column outlet signal and accumulated flow parameters for the at least one mobile phase transition front. A height equivalent theoretical plate (HETP) value is calculated for the at least one mobile phase transition front using parameters of the model gamma cumulative distribution curve and the quality of the chromatography column packing is assessed based on the calculated HETP value.
A method of operating a chromatography column in methods of manufacture for producing anti-TNF antibodies,
Dependencies are inferred from the claim text.